Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description We employ up to 120 staff each season which gives Alpine Elements a unique advantage in offering the chance to work summer or winter and, if visa restrictions allow, back-to-back seasonal opportunities. With a